2.Genome-wide long non-coding RNA association study on Han Chinese women identifies lncHSAT164 as a novel susceptibility gene for breast cancer.
Jing-Kai XU ; Guo-Zheng LI ; Zhi LI ; Wen-Jing LI ; Run-Sheng CHEN ; Bo ZHANG ; Xue-Jun ZHANG
Chinese Medical Journal 2021;134(10):1138-1145
BACKGROUND:
Single-nucleotide polymorphisms (SNPs)-associated genes and long non-coding RNAs (lncRNAs) can contribute to human disease. To comprehensively investigate the contribution of lncRNAs to breast cancer, we performed the first genome-wide lncRNA association study on Han Chinese women.
METHODS:
We designed an lncRNA array containing >800,000 SNPs, which was incorporated into a 96-array plate by Affymetrix (CapitalBio Technology, China). Subsequently, we performed a two-stage genome-wide lncRNA association study on Han Chinese women covering 11,942 individuals (5634 breast cancer patients and 6308 healthy controls). Additionally, in vitro gain or loss of function strategies were performed to clarify the function of a novel SNP-associated gene.
RESULTS:
We identified a novel breast cancer-associated susceptibility SNP, rs11066150 (Pmeta = 2.34 × 10-8), and a previously reported SNP, rs9397435 (Pmeta = 4.32 × 10-38), in Han Chinese women. rs11066150 is located in NONHSAT164009.1 (lncHSAT164), which is highly expressed in breast cancer tissues and cell lines. lncHSAT164 overexpression promoted colony formation, whereas lncHSAT164 knockdown promoted cell apoptosis and reduced colony formation by regulating the cell cycle.
CONCLUSIONS
Based on our lncRNA array, we identified a novel breast cancer-associated lncRNA and found that lncHSAT164 may contribute to breast cancer by regulating the cell cycle. These findings suggest a potential therapeutic target in breast cancer.
Asian Continental Ancestry Group/genetics*
;
Breast Neoplasms/genetics*
;
Case-Control Studies
;
China
;
Female
;
Genetic Predisposition to Disease/genetics*
;
Genome-Wide Association Study
;
Humans
;
Polymorphism, Single Nucleotide/genetics*
;
RNA, Long Noncoding/genetics*
4.Analysis of pathogenic variants in a Chinese pedigree affected with hyaline fibromatosis syndrome.
Jianmei YANG ; Xiaohong SHANG ; Fan LIU ; Qian WANG ; Caihong LIU ; Yan SUN ; Guimei LI
Chinese Journal of Medical Genetics 2021;38(3):232-237
OBJECTIVE:
To explore the clinical characteristics and genetic basis for a pair of twins affected with hyaline fibromatosis syndrome (HFS).
METHODS:
Clinical data of the twins were retrospectively analyzed. High-throughput sequencing was carried out to detect potential pathogenic variants. CLUSTALX was employed to analyze cross-species conservation of the mutant amino acids. Impact of the mutations was predicted by using software including PolyPhen-2 and Mutation taster.
RESULTS:
The pair of twins have featured growth and intelligence retardation, and were found to carry compound heterozygous variants of the ANTXR2 gene including c.1214G>A and c.1074delT, among which c.1214G>A was unreported previously. Both variants were predicted to be pathogenic. In addition to growth and mental delay, the pair of twins also featured hyperplasia of the gum and soft tissue-like masses of the auricle. The younger brother had rupture of the auricle mass during follow-up.
CONCLUSION
The patients' condition can probably be attributed to the compound heterozygous variants of the ANTXR2 gene. Above finding has facilitated molecular diagnosis of the patients.
Asian Continental Ancestry Group/genetics*
;
China
;
Humans
;
Hyalinosis, Systemic/genetics*
;
Male
;
Mutation
;
Pedigree
;
Receptors, Peptide/genetics*
;
Retrospective Studies
5.Genetic polymorphisms of 21 non-combined of DNA index system short tandem repeat loci in Hainan Li population.
Tao LI ; Yaqing ZHANG ; Ying'ai ZHANG
Chinese Journal of Medical Genetics 2021;38(5):503-505
OBJECTIVE:
To investigate the genetic polymorphisms of 21 non-combined DNA index system short tandem repeat (STR) loci in Hainan Li population.
METHODS:
DNA samples from 339 unrelated healthy individuals of Li population from Hainan Province were extracted and amplified with fluorescence labeled multiplex PCR system. PCR products were electrophoresed on an ABI3130 Genetic Analyzer following the manufacturer's instructions. Allele designation was performed with a GeneMapper ID-X by comparison with the allele ladder provided by the corresponding kit.
RESULTS:
A total of 173 alleles and 489 genotypes were observed for the 21 STR loci, respectively. The frequencies of alleles and genotypes were 0.0010-0.5434 and 0.0020-0.3274, respectively. The heterozygosity varied from 0.639 to 0.833. Discrimination power (DP) was 0.803-0.948, power of exclusion for trio-paternity was 0.416-0.584, power of exclusion for duo-paternity was 0.140-0.238, the polymorphism information content(PIC) was 0.57-0.81, respectively. The total discrimination power (TDP), cumulative probability of exclusion for trio-paternity testing(CPE-trio) and cumulative probability of exclusion for duo-paternity testing (CPE-duo) were 0.999 999 999 999 99, 0.999 999 883 211 752, and 0.987 266, respectively.
CONCLUSION
The 21 STR loci are highly polymorphic and informative in the studied population and can be employed as supplementary loci in duo-paternity testing or cases with variant circumstances.
Asian Continental Ancestry Group/genetics*
;
China
;
DNA
;
Gene Frequency
;
Genetics, Population
;
Humans
;
Microsatellite Repeats/genetics*
;
Polymorphism, Genetic
6.Genetic polymorphism of 23 autosomal STR loci in Han population from Yuncheng, Shanxi Province.
Hongyan GAO ; Jian YU ; Xiaodan FENG ; Xiaohong WU ; Li LUO ; Xianfeng LI ; Chao LIU ; Pengyu CHEN
Journal of Central South University(Medical Sciences) 2021;46(4):351-360
OBJECTIVES:
Due to the genetic feature of high diversity than other DNA markers, short tandem repeat (STR) plays key roles in forensic, anthropology, and population genetics. Newly introduced multiple STR kit is more valuable because of the greatly improved discriminatory power with the increase in the number of STR loci. The genetic polymorphic data are essential for the application and research in specific population. This study aims to investigate the genetic polymorphism of Han population residing in Yuncheng district, Shanxi Province, to evaluate the application of 23 STR loci in forensic personal identification and paternity test, and to explore the genetic relationship of Han population between Yuncheng and other populations.
METHODS:
A total of 23 STR loci were amplified from 525 healthy unrelated individuals from the Han nationality in Yuncheng, Shanxi Province using the AGCU EX25 amplification kit. The products were detected and separated by ABI 3500 Genetic Analyzer. Alleles were genotyped by GeneMapper ID (Version 3.2) software, and corresponding frequencies and forensic parameters were calculated. We calculated the genetic distance and plotted the neighboring-joining tree with other 13 population.
RESULTS:
The allele frequency of the 23 STRs ranged from 0.0010 to 0.5090. No deviation from Hardy-Weinberg equilibrium (
CONCLUSIONS
These 23 STRs are highly genetic polymorphic and informative in the Han population of Yuncheng, Shanxi Province, which can provide basic data for forensic personal identification, paternity testing, and population genetic research.
Asian Continental Ancestry Group/genetics*
;
China
;
Ethnic Groups/genetics*
;
Gene Frequency
;
Genetic Loci
;
Genetics, Population
;
Humans
;
Microsatellite Repeats/genetics*
;
Polymorphism, Genetic
7.Rare variants of HSPB1 are probably associated with amyotrophic lateral sclerosis.
Junyi CHEN ; Xiangyi LIU ; Yingsheng XU ; Dongsheng FAN
Journal of Southern Medical University 2021;41(1):75-78
OBJECTIVE:
To explore the association between rare HSPB1 variants and amyotrophic lateral sclerosis (ALS).
METHODS:
We performed next-generation sequencing for 166 Chinese ALS patients to screen for possible pathogenic rare variants of HSPB1. The control individuals were obtained from 1000 Genome Project and an in-house whole-exome sequencing database. The Sequence Kernel Association Test (SKAT) and the SKAT-optimal test (SKAT-O) were used to identify the association between rare HSPB1 variants and ALS.
RESULTS:
We identified 3 possible pathogenic rare variants of HSPB1 (all were missenses), including c.379C>T (p.R127W), c.446A>C (p.D149A) and c.451A>C (p.T151P). Compared with 1000 Genome Project, SKAT p=3.61×10
CONCLUSIONS
Rare variants of HSPB1 are probably associated with the pathogenesis of ALS.
Amyotrophic Lateral Sclerosis/genetics*
;
Asian Continental Ancestry Group
;
Heat-Shock Proteins
;
Heterozygote
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Molecular Chaperones
;
Phenotype
8.Genetic profile of Chinese patients with Charcot-Marie-Tooth disease.
Zhi-Yuan OUYANG ; You CHEN ; Da-Qiang QIN ; Zhi-Dong CEN ; Xiao-Sheng ZHENG ; Fei XIE ; Si CHEN ; Hao-Tian WANG ; De-Hao YANG ; Xin-Hui CHEN ; Le-Bo WANG ; Bao-Rong ZHANG ; Wei LUO
Chinese Medical Journal 2020;133(21):2633-2634
9.Analysis of gene variant in a Chinese child affected with dihydropyrimidinase deficiency.
Jianbo SHU ; Fengying CAI ; Xiaowei XU ; Xinjie ZHANG ; Xuetao WANG ; Jie ZHENG ; Chunhua ZHANG ; Chunqun CAI ; Shuxiang LIN ; Yuqin ZHANG
Chinese Journal of Medical Genetics 2020;37(11):1241-1243
OBJECTIVE:
To analyze the molecular etiology of a Chinese child affected with dihydropyrimidinase deficiency.
METHODS:
Genomic DNA was extracted from peripheral blood samples of the family members. Pathogenic variant was determined by whole exome sequencing and verified by Sanger sequencing.
RESULTS:
The child was found to harbor homozygous c.905G>A (p.Arg302Gln) variants in exon 5 of the DPYS gene, for which her parents were both heterozygous carriers.
CONCLUSION
The homozygous c.905G>A (p.Arg302Gln) variants of the DPYS gene probably underlies the dihydropyrimidinase deficiency in the child. Above result has enabled genetic counseling and prenatal diagnosis for this family.
Amidohydrolases/genetics*
;
Asian Continental Ancestry Group/genetics*
;
Child
;
Exons
;
Female
;
Humans
;
Metabolism, Inborn Errors/genetics*
;
Mutation
;
Pedigree
10.Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis
Zheng LIU ; Jianjun CHEN ; Lei CHENG ; Huabin LI ; Shixi LIU ; Hongfei LOU ; Jianbo SHI ; Ying SUN ; Dehui WANG ; Chengshuo WANG ; Xiangdong WANG ; Yongxiang WEI ; Weiping WEN ; Pingchang YANG ; Qintai YANG ; Gehua ZHANG ; Yuan ZHANG ; Changqing ZHAO ; Dongdong ZHU ; Li ZHU ; Fenghong CHEN ; Yi DONG ; Qingling FU ; Jingyun LI ; Yanqing LI ; Chengyao LIU ; Feng LIU ; Meiping LU ; Yifan MENG ; Jichao SHA ; Wenyu SHE ; Lili SHI ; Kuiji WANG ; Jinmei XUE ; Luoying YANG ; Min YIN ; Lichuan ZHANG ; Ming ZHENG ; Bing ZHOU ; Luo ZHANG
Allergy, Asthma & Immunology Research 2020;12(2):176-237
The current document is based on a consensus reached by a panel of experts from the Chinese Society of Allergy and the Chinese Society of Otorhinolaryngology-Head and Neck Surgery, Rhinology Group. Chronic rhinosinusitis (CRS) affects approximately 8% of Chinese adults. The inflammatory and remodeling mechanisms of CRS in the Chinese population differ from those observed in the populations of European descent. Recently, precision medicine has been used to treat inflammation by targeting key biomarkers that are involved in the process. However, there are no CRS guidelines or a consensus available from China that can be shared with the international academia. The guidelines presented in this paper cover the epidemiology, economic burden, genetics and epigenetics, mechanisms, phenotypes and endotypes, diagnosis and differential diagnosis, management, and the current status of CRS in China. These guidelines—with a focus on China—will improve the abilities of clinical and medical staff during the treatment of CRS. Additionally, they will help international agencies in improving the verification of CRS endotypes, mapping of eosinophilic shifts, the identification of suitable biomarkers for endotyping, and predicting responses to therapies. In conclusion, these guidelines will help select therapies, such as pharmacotherapy, surgical approaches and innovative biotherapeutics, which are tailored to each of the individual CRS endotypes.
Adult
;
Asian Continental Ancestry Group
;
Biomarkers
;
China
;
Consensus
;
Diagnosis
;
Diagnosis, Differential
;
Drug Therapy
;
Eosinophils
;
Epidemiology
;
Epigenomics
;
Genetics
;
Humans
;
Hypersensitivity
;
Inflammation
;
International Agencies
;
Medical Staff
;
Neck
;
Phenotype
;
Precision Medicine

Result Analysis
Print
Save
E-mail